Fatal food anaphylaxis in adults and children.
Drug allergy
Epinephrine
Fatal anaphylaxis
Food allergy
Prevention
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
05 Mar 2024
05 Mar 2024
Historique:
received:
28
09
2023
accepted:
11
02
2024
medline:
5
3
2024
pubmed:
5
3
2024
entrez:
4
3
2024
Statut:
epublish
Résumé
Anaphylaxis is a life-threatening reaction characterized by the acute onset of symptoms involving different organ systems and requiring immediate medical intervention. The incidence of fatal food anaphylaxis is 0.03 to 0.3 million/people/year. Most fatal food-induced anaphylaxis occurs in the second and third decades of life. The identified risk factors include the delayed use of epinephrine, the presence of asthma, the use of recreational drugs (alcohol, nicotine, cannabis, etc.), and an upright position. In the United Kingdom (UK) and Canada, the reported leading causal foods are peanuts and tree nuts. In Italy, milk seems to be the most common cause of fatal anaphylaxis in children < 18 years. Fatal food anaphylaxis in Italian children and adolescents almost always occurs outside and is characterized by cardiorespiratory arrest; auto-injectable adrenaline intramuscular was available in few cases. Mortality from food anaphylaxis, especially in children, is a very rare event with stable incidence, but its risk deeply impacts the quality of life of patients with food allergy and their families. Prevention of fatal food anaphylaxis must involve patients and their families, as well as the general public, public authorities, and patients' associations.
Identifiants
pubmed: 38439086
doi: 10.1186/s13052-024-01608-x
pii: 10.1186/s13052-024-01608-x
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
40Informations de copyright
© 2024. The Author(s).
Références
Muraro A, Worm M, Alviani C, Cardona V, DunnGalvin A, Garvey LH, et al. EAACI guidelines: Anaphylaxis (2021 update). Allergy. 2022;77(2):357–77. https://doi.org/10.1111/all.15032 . Epub 2021 Sep 1. PMID: 34343358.
doi: 10.1111/all.15032
pubmed: 34343358
Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fernandez Rivas M, Fineman S, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020;13(10):100472 https://doi.org/10.047210.1016/j.waojou.2020.100472 . PMID: 33204386; PMCID: PMC7607509.
doi: 10.1016/j.waojou.2020.100472
pubmed: 33204386
pmcid: 7607509
Panesar SS, Javad S, de Silva D, Nwaru BI, Hickstein L, Muraro A, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013;68:1353–61.
doi: 10.1111/all.12272
pubmed: 24117770
Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med. 2001;161:15–21.
doi: 10.1001/archinte.161.1.15
pubmed: 11146694
Mikhail I, Stukus DR, Prince BT. Fatal anaphylaxis: epidemiology and risk factors. Curr Allergy Asthma Rep. 2021;21:28.
doi: 10.1007/s11882-021-01006-x
pubmed: 33825067
Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133:1075–83.
doi: 10.1016/j.jaci.2013.10.029
pubmed: 24332862
Pouessel G, Claverie C, Labreuche J, Dorkenoo A, Renaudin JM, Eb M, et al. Fatal anaphylaxis in France: analysis of national anaphylaxis data, 1979–2011. J Allergy Clin Immunol. 2017;140(2):610–2.
doi: 10.1016/j.jaci.2017.02.014
pubmed: 28283420
Pumphrey RSH. Fatal anaphylaxis in the UK, 1992–2001. Novartis Found Symp. 2004;257:116–28. Discussion 128–132, 157–160, 276–285.
doi: 10.1002/0470861193.ch10
pubmed: 15025395
Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol. 2009;123:434–42.
doi: 10.1016/j.jaci.2008.10.049
pubmed: 19117599
Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract. 2017;5(5):1169–78.
doi: 10.1016/j.jaip.2017.06.031
pubmed: 28888247
pmcid: 5589409
Turner PJ, Campbell DE, Motosue MS, Campbell RL. Global trends in anaphylaxis epidemiology and clinical implications. J Allergy Clin Immunol Pract. 2020;8(4):1169–76.
doi: 10.1016/j.jaip.2019.11.027
pubmed: 31786255
pmcid: 7152797
Ansotegui IJ, Sánchez-Borges M, Cardona V. Current trends in prevalence and mortality of anaphylaxis. Curr Treat Options Allergy. 2016;3:205–11.
doi: 10.1007/s40521-016-0094-0
Simons FE, Ardusso LR, Bilò MB, El-Gamal YM, Ledford DK, Ring J, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011;4(2):13–37.
doi: 10.1097/WOX.0b013e318211496c
pubmed: 23268454
pmcid: 3500036
Tanno LK, Ganem F, Demoly P, Toscano CM, Bierrenbach AL. Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10. Allergy. 2012;67:783–9.
doi: 10.1111/j.1398-9995.2012.02829.x
pubmed: 22519410
Sharma V, Garcez T, Fox AT. Fatal anaphylaxis: making sure alla cases are counted. BMJ. 2021;372:n691.
doi: 10.1136/bmj.n691
pubmed: 33722848
Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012. J Allergy Clin Immunol. 2015;135:956-63.e1.
doi: 10.1016/j.jaci.2014.10.021
pubmed: 25468198
pmcid: 4382330
Bilò MB, Corsi A, Martini M, Penza E, Grippo F, Bignardi D. Fatal anaphylaxis in Italy: analysis of cause-of-death national data, 2004–2016. Allergy. 2020;75:2644–52.
doi: 10.1111/all.14352
pubmed: 32364284
Jerschow E, Lin RY, Scaperotti MM, McGinn AP. Fatal anaphylaxis in the United States, 1999–2010: temporal patterns and demographic associations. J Allergy Clin Immunol. 2014;134(6):1318-1328.e7. https://doi.org/10.1016/j.jaci.2014.08.018 .
doi: 10.1016/j.jaci.2014.08.018
pubmed: 25280385
pmcid: 4260987
Xu YS, Kastner M, Harada L, Xu A, Salter J, WasermanS. Anaphylaxis-related deaths in Ontario: a retrospective review of cases from,. to 2011. Allergy Asthma Clin Immunol. 1986;2014(10):38.
Pouessel G, Alonzo S, Divaret-Chauveau A, Dumond P, Bradatan E, Liabeuf V, et al. Fatal and near-fatal anaphylaxis: the Allergy-Vigilance® Network data (2002–2020). Allergy. 2023;78(6):1628–38. https://doi.org/10.1111/all.15645 . Epub 2023 Jan 24.
doi: 10.1111/all.15645
pubmed: 36645170
Michelson KA, Dribin TE, Vyles D, Neuman MI. Trends in emergency care for anaphylaxis. J Allergy Clin Immunol Pract. 2020;8(2):767-768.e2.
doi: 10.1016/j.jaip.2019.07.018
pubmed: 31466851
Mullins RJ, Wainstein BK, Barnes EH, Liew WK, Campbell DE. Increases in anaphylaxis fatalities in Australia from 1997 to 2013. Clin Exp Allergy. 2016;46:1099–110.
doi: 10.1111/cea.12748
pubmed: 27144664
Turner PJ, Campbell DE. Epidemiology of severe anaphylaxis: can we use population-based data to understand anaphylaxis? Curr Opin Allergy Clin Immunol. 2016;16:441–50.
doi: 10.1097/ACI.0000000000000305
pubmed: 27490124
pmcid: 5325322
Baseggio Conrado A, Ierodiakonou D, Gowland MH, Boyle RJ, Turner PJ. Food anaphylaxis in the United Kingdom: analysis of nationaldata, 1998–2018. BMJ. 2021;372:n251.
doi: 10.1136/bmj.n251
pubmed: 33597169
pmcid: 7885259
Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA, Campbell RL, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082–123.
doi: 10.1016/j.jaci.2020.01.017
pubmed: 32001253
Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999–2006. J Allergy Clin Immunol. 2007;119:1018–9.
doi: 10.1016/j.jaci.2007.01.021
pubmed: 17349682
Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol. 2004;4:285–90.
doi: 10.1097/01.all.0000136762.89313.0b
pubmed: 15238794
Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;327(6):380–4. https://doi.org/10.1056/NEJM199208063270603 .
doi: 10.1056/NEJM199208063270603
pubmed: 1294076
Macdougall CF, Cant AJ, Colver AF. How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across the UK and Ireland. Arch Dis Child. 2002;86:236–9.
doi: 10.1136/adc.86.4.236
pubmed: 11919093
pmcid: 1719140
Calvani M, Di Lallo D, Spinelli A, Polo A. Epidemiologia della anafilassi in Italia. Rivista di Immunologia e Allergologia Pediatrica. 2006;5:23–8.
Bock SA, Muñoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol. 2007;119(4):1016–8. https://doi.org/10.1016/j.jaci.2006.12.622 .
Levy MB, Goldberg MR, Nachshon L, Tabachnik E, Katz Y. Lessons from cases of mortality due to food allergy in Israel: cow’s milk protein should be considered a potentially fatal allergen. Isr Med Assoc J. 2012;14(1):29–33.
pubmed: 22624439
Pouessel G, Tanno LK, Claverie C, Lejeune S, Labreuche J, Dorkenoo A, et al. Fatal anaphylaxis in children in France: analysis of national data. Pediatr Allergy Immunol. 2018;29(1):101–4. https://doi.org/10.1111/pai.12828 .
doi: 10.1111/pai.12828
pubmed: 29047172
Cox AL, Nowak-Wegrzyn A. Innovation in food challenge tests for food allergy. Curr Allergy Asthma Rep. 2018;18(12):74.
doi: 10.1007/s11882-018-0825-3
pubmed: 30377836
Spergel JM. Natural history of cow’s milk allergy. J Allergy Clin Immunol. 2013;131:813–4.
doi: 10.1016/j.jaci.2013.01.027
pubmed: 23452903
Elizur A, Rajuan N, Goldberg MR, Leshno M, di Cohen A, Katz Y. Natural course and risk factors for persistence of IgE-mediated cow’s milk allergy. J Pediatr. 2012;161(3):482-487.e1. https://doi.org/10.1016/j.jpeds.2012.02.028 . Epub 2012 Apr 4.
doi: 10.1016/j.jpeds.2012.02.028
pubmed: 22480700
Koike Y, Sato S, Yanagida N, Asaumi T, Ogura K, Ohtani K, et al. Predictors of persistent milk allergy in children: a retrospective cohort study. Int Arch Allergy Immunol. 2018;175(3):177–80. https://doi.org/10.1159/000486311 . Epub 2018 Jan 23.
doi: 10.1159/000486311
pubmed: 29393170
Järvinen KM, Beyer K, Vila L, Chatchatee P, Busse PJ, Sampson HA. B-cell epitopes as a screening instrument for persistent cow’s milk allergy. J Allergy Clin Immunol. 2002;110(2):293–7. https://doi.org/10.1067/mai.2002.126080 .
doi: 10.1067/mai.2002.126080
pubmed: 12170271
Greenhawt M. Environmental exposure to peanut and the risk of an allergic reaction. Ann Allergy Asthma Immunol. 2018;120(5):476-481.e473.
doi: 10.1016/j.anai.2018.03.011
pubmed: 29555352
Muraro A, Agache I, Clark A, Sheikh A, Roberts G, Akdis CA, et al. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community. Allergy. 2014;69(8):1046–57.
doi: 10.1111/all.12441
pubmed: 24905609
Nurmatov U, Dhami S, Arasi S, Pajno GB, Fernandez-Rivas M, Muraro A, et al. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy. 2017;72:1133–47.
doi: 10.1111/all.13124
pubmed: 28058751
Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro-Lozano M, et al. EAACI guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018;73:799–815.
doi: 10.1111/all.13319
pubmed: 29205393
Vazquez-Ortiz M, Turner PJ. Improving the safety of oral immunotherapy for food allergy. Pediatr Allergy Immunol. 2016;27:117–25.
doi: 10.1111/pai.12510
pubmed: 26593873
Ogata M, Kido J, Nakamura K. Oral immunotherapy for children with cow’s milk allergy. Pathogens. 2021;10(10):1328.
doi: 10.3390/pathogens10101328
pubmed: 34684278
pmcid: 8539286
Benelli E, Trombetta A, Badina L, Andrade S, Zamagni G, Prisco A, et al. Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy. Immun Inflamm Dis. 2022;10:e668.
doi: 10.1002/iid3.668
pubmed: 35759227
pmcid: 9208286
Blumchen K, Trendelenburg V, Ahrens F, Gruebl A, Hamelmann E, Hansen G, et al. Efficacy, safety, and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy. J Allergy Clin Immunol Pract. 2019;7:479-491.e10.
doi: 10.1016/j.jaip.2018.10.048
pubmed: 30423449
Epstein-Rigbi N, Goldberg MR, Levy MB, Nachshon L, Elizur A. Quality of life of food-allergic patients before, during, and after oral immuno- therapy. J Allergy Clin Immunol Pract. 2019;7:429-436.e2.
doi: 10.1016/j.jaip.2018.06.016
pubmed: 30129441
Otani IM, Bégin P, Kearney C, Dominguez TL, Mehrotra A, Bacal LR, et al. Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric subjects. Allergy Asthma Clin Immunol. 2014;10(1):25. https://doi.org/10.1186/1710-1492-10-25 . eCollection 2014.
doi: 10.1186/1710-1492-10-25
pubmed: 24860608
pmcid: 4032627
Turner PJ, Arasi S, Ballmer-Weber B, Baseggio Conrado A, Deschildre A, Gerdts J, et al. Risk factors for severe reactions in food allergy: rapid evidence review with meta-analysis. Allergy. 2022;77(9):2634–52.
doi: 10.1111/all.15318
pubmed: 35441718
Lyons SA, Datema MR, Le TM, Asero R, Barreales R, Belohlavkova S, et al. Walnut allergy across Europe:distribution of allergen sensitization patterns and prediction of severity. J Allergy Clin Immunol Pract. 2021;9(1):225-235.e10.
doi: 10.1016/j.jaip.2020.08.051
pubmed: 32916320
Comberiati P, Spahn J, Peroni DG. Anaphylaxis in adolescents. Curr Opin Allergy Clin Immunol. 2019;19(5):425–31. https://doi.org/10.1097/ACI.0000000000000572 .
doi: 10.1097/ACI.0000000000000572
pubmed: 31318740
Decimo F, Anania A, Cuomo B, D'Auria E, Indirli GC, Manca E, et al. Gestione dell’anafilassi: aggiornamento pratico per il pediatra (con particolare riferimento all’anafilassi da alimenti). 2023;37(2):Fascicolo 2 - Anno 2023. https://doi.org/10.53151/2531-3916/2023-99 .
Dribin TE, Waserman S, Turner PJ. Who Needs Epinephrine? Anaphylaxis, Autoinjectors, and Parachutes. J Allergy Clin Immunol Pract. 2023;11(4):1036–46. https://doi.org/10.1016/j.jaip.2023.02.002 . Epub 2023 Feb 14.
doi: 10.1016/j.jaip.2023.02.002
pubmed: 36796511
pmcid: 10259181